...

首页> 外文期刊>The lancet. Respiratory medicine. >Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial (vol 9 pg 260, 2021)

【24h】

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial (vol 9 pg 260, 2021)

机译：对患有本土（ANDHI）治疗的严重嗜酸性哮喘患者的效果和对健康相关质量，加剧率，肺功能和鼻息肉症状的效果和影响的影响 2021）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The lancet. Respiratory medicine.》 |2021年第3期|共1页
作者
Harrison Tim W.; Chanez Pascal; Menzella Francesco; Canonica Giorgio Walter; Louis Renaud; Cosio Borja G.; Lugogo Njira L.; Mohan Arjun; Burden Annie; McDermott Lawrence; Garcia Gil Esther; Zangrilli James G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献

1. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial [J] . Harrison Tim W., Chanez Pascal, Menzella Francesco, The lancet. Respiratory medicine. . 2021,第3期

机译：对患有本土（ANDHI）治疗的严重嗜酸性哮喘患者的效果和影响对健康相关质量，恶化率，肺功能和鼻息肉症状的影响
2. Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [J] . Reynold A Panettieri Jr, Tobias Welte, Kartik V Shenoy, Journal of Asthma and Allergy . 2020,第3期

机译：效果，气流梗阻和肺部变化的变化，以及与Benralizumab对患有严重嗜酸性哮喘的患者的健康有关的生活质量改善：IIIB阶段随机，受控试验（索兰）
3. Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose [J] . Pelaia Corrado, Busceti Maria Teresa, Vatrella Alessandro, Pulmonary pharmacology & therapeutics . 2019,第期

机译：患有严重过敏性嗜酸性嗜酸性哮喘患者的本利国效应的现实生活效果：第一种药物剂量后，血液嗜酸性粒细胞的评估，症状控制，肺功能和口腔皮质类固醇摄入量
4. Onset of Effect Changes in Airflow Obstruction and Lung Volume and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized Controlled Trial (SOLANA) Corrigendum [O] . 2020

机译：贝拉珠单抗对严重嗜酸性粒细胞性哮喘患者的发作气流阻塞和肺体积的变化以及与健康有关的生活质量改善：IIIb期随机对照试验（更正）更正
5. Exacerbation Reduction and Early and Sustained Improvements in SGRQ, Lung Function, and Symptoms of Nasal Polyposis with Benralizumab for Severe, Eosinophilic Asthma: Phase IIIb ANDHI Trial [O] . T.W. Harrison, P. Chanez, F. Menzella, 2020

机译：恶化的减少和早期和持续改善SGRQ，肺功能和鼻息肉症状的鼻息肉，嗜酸性嗜酸性哮喘：IIIB和他试验

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号